U.S. market Closed. Opens in 5 hours 53 minutes

KRON | Kronos Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
Revenue6.29MN/AN/AN/AN/AN/A
Cost of Revenue4.92M4.46M4.08M4.87M605.00KN/A
Gross Profit1.37M-4.46M-4.08M-4.87M-605.00KN/A
Operating Expenses120.30M137.12M151.40M58.04M16.82M6.64M
Selling, General & Admin37.96M43.40M38.49M14.79M3.37M1.61M
Research & Development82.34M93.72M112.90M43.25M13.45M5.03M
Other Operating Expenses-606.00KN/AN/A-27.41MN/AN/A
Operating Income-118.93M-137.12M-151.40M-58.04M-16.82M-6.64M
Other Expenses / Income6.26M3.91M320.00K-30.40M699.00K-76.00K
Before Tax Income-112.67M-133.20M-151.08M-88.44M-16.12M-6.72M
Income Tax Expenses4.75M-3.91M-1.98M-24.36M-699.00KN/A
Net Income-112.67M-129.29M-149.10M-64.09M-15.42M-6.72M
Interest Expenses9.16M-2.27MN/A3.89MN/A76.00K
Basic Shares Outstanding57.74M56.20M54.75M54.07M53.04M28.45M
Diluted Shares Outstanding57.74M56.20M54.75M54.07M53.04M28.45M
EBITDA-114.01M-137.12M-151.08M-84.55M-16.46M-6.55M
EBITDA Margin-1,813.20%0.00%0.00%0.00%0.00%0.00%
EBIT-98.77M-135.47M-151.08M-84.55M-16.12M-6.64M
EBIT Margin-1,570.74%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙